Harima Chemicals GroupHARIMA CHEMICALS GROUP, INC.4410東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥3 is left as operating profit. Revenue changed +2.7% from the prior year, operating profit +57.6%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 2.3% | 0.96× | 2.2% | 2.08× | 4.6% |
| 2023 | 0.9% | 1.10× | 1.0% | 2.29× | 2.4% |
| 2024 | — | —× | -1.2% | —× | — |
| 2025 | 0.8% | 1.02× | 0.8% | 2.91× | 2.2% |
| 2026 | 2.3% | 1.02× | 2.3% | 2.97× | 6.9% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 76,093 | 94,510 | 92,330 | 101,006 | 103,763 |
| Cost of revenue | 58,116 | 75,300 | 74,408 | 79,211 | 80,823 |
| Gross profit | 17,977 | 19,210 | 17,921 | 21,795 | 22,939 |
| SG&A | 14,726 | 17,504 | 18,133 | 19,711 | 19,656 |
| Operating income | 3,251 | 1,706 | -211 | 2,083 | 3,283 |
| Pretax income | 2,995 | 2,323 | -251 | 1,818 | 3,174 |
| Income tax | 882 | 1,038 | 639 | 1,039 | 831 |
| Net income attributable to owners | 1,746 | 885 | -1,161 | 763 | 2,345 |
| Operating margin | 4.3% | 1.8% | -0.2% | 2.1% | 3.2% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥5.34B | ¥6.22B | ¥6.63B | ¥4.64B | ¥6.18B |
| Total assets | ¥78.9B | ¥92.4B | ¥98.6B | ¥100B | ¥102.9B |
| Net assets | ¥40.1B | ¥40.8B | ¥40.9B | ¥38B | ¥41.5B |
| Share capital | ¥10B | ¥10B | ¥10B | ¥10B | ¥10B |
| Trade receivables | ¥20.1B | ¥22.3B | ¥21.8B | ¥20.8B | ¥20.7B |
| Property, plant and equipment | ¥23.4B | ¥27.1B | ¥28.5B | ¥32.4B | ¥33.8B |
| Intangible assets excluding goodwill | ¥712.9M | ¥5.23B | ¥4.99B | ¥4.69B | ¥4.39B |
| Investment securities | ¥8.86B | ¥8.97B | ¥9.99B | ¥9.29B | ¥9.47B |
| Current assets | ¥44.2B | ¥49.8B | ¥53.6B | ¥52.1B | ¥53.4B |
| Current liabilities | ¥23.1B | ¥41.7B | ¥47.7B | ¥45.9B | ¥41B |
| Trade payables | ¥10.6B | ¥10.3B | ¥10.7B | ¥11B | ¥9.33B |
| Short-term borrowings | ¥7.72B | ¥18.3B | ¥29.9B | ¥28.1B | ¥21B |
| Long-term borrowings | ¥12.7B | ¥6.18B | ¥6.2B | ¥11.7B | ¥15.9B |
| Total liabilities | ¥38.8B | ¥51.6B | ¥57.7B | ¥62B | ¥61.4B |
| Non-controlling interests | ¥3.36B | ¥3.72B | ¥3.66B | ¥677M | ¥706M |
| Equity attributable to owners of parent | ¥37.9B | ¥37B | ¥34.8B | ¥33.5B | ¥34.8B |
| Retained earnings | ¥19.1B | ¥19B | ¥16.8B | ¥16.6B | ¥17.9B |
| Treasury stock | -¥964.7M | -¥1.79B | -¥1.76B | -¥1.73B | -¥1.69B |
EDINET (FSA Japan)
有価証券報告書-第84期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第83期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第82期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第81期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
有価証券報告書-第80期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第79期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 54 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.